glp 1 and kidney cancer GLP-1 Side Effects May Increase Risks: Study Potential kidney-protective and other effects

1 with semaglutide ( n = 469)

Disrupted methionine cycle triggers muscle atrophy in cancer cachexia through epigenetic regulation of REDD1

Alternative 20-day extended protocol Extended cycle approach: Duration: 20 consecutive days Dose: 5-10mg per day Total: 100-200mg per cycle Frequency: Every 6-12 months Goal: Deeper, more sustained effects Why 20 days: Allows more comprehensive cellular changes Telomere lengthening may be more pronounced Some users report stronger anti-aging benefits Less frequent cycling (only 1-2x per year) Higher total peptide investment 20-day protocol comparison: Who uses 20-day protocol: Users wanting longer cycles with less frequent dosing Those who respond well to extended peptide therapy Individuals combining with other anti-aging interventions People who prefer fewer total cycles Potential advantages: May produce more sustained benefits Fewer cycles = less injection burden Possibly stronger gene expression changes Some report better sleep normalization Potential disadvantages: Higher per-cycle cost More injection days consecutively Less opportunity to assess response before next cycle No evidence it's superior to 10-day protocol Learn about cycling different peptides at SeekPeptides

Ongoing research The semaglutide-allodynia connection is an active area of investigation